785 articles
Bovine leukemia virus found in human breast tumors may account for up to 52% of cases, with infection preceding cancer by years.
Men taking PDE-5 inhibitors like Viagra had up to 3% lower glaucoma risk, suggesting vascular eye benefits beyond sexual health.
5-year PROFILE trial data show top-down immunotherapy slashes surgeries, hospitalizations, and disease progression vs standard step-up care.
A Japanese study of 495 centenarians finds elevated NfL blood levels strongly linked to worse cognition and 36% higher mortality risk.
Two adolescents with T1D and obesity saw major metabolic gains from low-dose semaglutide, cutting insulin needs and improving blood sugar control.
New mouse research reveals how intestinal aging creates a feedback loop of inflammation, barrier breakdown, and microbiome decline.
A GLP-1 receptor agonist targeting neuroinflammation is now in a 120-patient trial measuring brain volume preservation in progressive MS.
ROKIT Healthcare reports zero tumor recurrence and improved healing using AI-guided fat tissue bioprinting to reconstruct skin cancer excision sites.
TUNE-401 targets the hepatitis B viral reservoir using epigenetic silencing, offering the first clinical proof of a potential finite cure.
New analyses of vutrisiran show consistent benefits in diverse heart amyloidosis patients, with a long-term observational study now underway.
Beacon Biosignals uses at-home EEG during sleep to spot early signs of Alzheimer's and Parkinson's, reshaping brain diagnostics.
A new startup aims to fix mRNA's biggest flaw — short duration — opening doors to immune and inflammation control across a lifetime.
